Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
about
Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat heartsMicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment.Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer.Magnetic resonance imaging with superparamagnetic iron oxide fails to track the long-term fate of mesenchymal stem cells transplanted into heartRemote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium.Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?Dynamic Tracking of Injected Mesenchymal Stem Cells after Myocardial Infarction in Rats: A Serial 7T MRI Study.Central zone of myocardial infarction: a neglected target area for heart cell therapyBiodistribution of locally or systemically transplantedosteoblast-like cells.Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.Systemic redistribution of the intramyocardially injected mesenchymal stem cells by repeated remote ischaemic post-conditioning.Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types
P2860
Q30559112-2664E4C9-3881-47E3-B02B-32098B54A00BQ34183068-26BA034F-4D9F-481E-AED5-FEE1790CC249Q34345561-0AF65136-2B97-4497-9DDD-35174CBB5695Q34621134-B3295B00-4161-460C-A33D-E87A8EDCE578Q35042364-9C83C6AC-AFDA-4628-BAB8-A189EE214C02Q35169539-0C764B14-90A7-4E5C-970E-ABC5B37296A5Q35892642-2C903F36-F357-4179-8380-2836AB2AD79AQ36802019-88493AAC-EA4B-4E39-AF0D-E23D3DBC5C9AQ37253137-68A615A3-4023-4ECC-9670-CD73F5221E8FQ37294829-5494A2F0-4D35-46D2-964D-9D5FC3110E5CQ38432111-C6F0C61D-C146-4AF1-8242-07AEC01A2A6AQ44953364-0E4ACF0B-BFCD-40F5-B323-25B1FAC670C3Q47117835-84F82B94-3774-4CA6-A759-531FD05986D1Q47913152-13142BCA-6F0B-41CD-ABD5-8B756C8AD483Q55332823-88ACAE43-6BE7-412D-9800-5386B2BC750BQ57176906-B18012D7-FFB1-4379-9130-5D5F80748FD8
P2860
Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Intravenous administration of ...... c myocardial infarction model.
@en
Intravenous administration of ...... c myocardial infarction model.
@nl
type
label
Intravenous administration of ...... c myocardial infarction model.
@en
Intravenous administration of ...... c myocardial infarction model.
@nl
prefLabel
Intravenous administration of ...... c myocardial infarction model.
@en
Intravenous administration of ...... c myocardial infarction model.
@nl
P2093
P2860
P356
P1476
Intravenous administration of ...... c myocardial infarction model.
@en
P2093
Peifeng Jin
Shengshou Hu
Yingjie Wei
P2860
P304
P356
10.2217/RME.10.104
P577
2011-03-01T00:00:00Z